Broach Lifecare (544231)

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 43.65% indicates strong demand for hospital services.
• ROCE of 9.45% suggests capital is being deployed productively, albeit modestly.
• Small market cap of ₹9 Cr leaves room for significant upside if the business model scales.
• PEG of 0.50 based on top-line growth could attract growth-focused investors.

Concerns

• Profit growth of -29.55% and latest quarter net profit of ~₹0 Cr show severe margin compression.
• P/E of 22 is not cheap when current earnings are nearly zero.
• Piotroski F-Score of 4/9 indicates weak overall financial health.
• Lack of data on book value, debt/equity, promoter holding, and 52-week range limits analytical confidence.

AI Analysis

Let me start with what I see: a hospital business with a market cap of ₹9 crore and a price-to-earnings multiple of 22. That strikes me as odd when the latest quarter shows net profit of roughly zero. Sales grew 43.65%, which sounds wonderful, but profit fell 29.55%. So the company is buying growth by sacrificing margins. As Graham would say, the numbers are the first place to look, and they don't yet prove a good business. With no book value, no debt-equity, and no promoter holding disclosed, I feel like I'm being asked to step into a tunnel with no torch. The Piotroski F-Score of 4 out of 9 is a lukewarm handshake—not enough to convince me of financial strength. ROCE is 9.45%, which covers the cost of capital only if you assume a very low hurdle rate. A dividend yield of zero means patient shareholders get nothing while they wait. I respect revenue growth; in healthcare, top-line gains can be meaningful. But a P/E of 22 and negative profit growth is a dangerous combination if the market is pricing in a turnaround. The PEG of 0.50 looks tempting, but it seems to use sales growth rather than shrinking earnings—so I'll discount that. This is a watchlist candidate, not a buy. I need to see profit margins stabilize and a positive net profit quarter. I also need transparency on ownership and leverage. Without that, I cannot calculate a margin of safety. In Buffett's world, a wonderful business at a fair price is good; a mediocre business at 22 times its last real earnings is speculation. Until the numbers start speaking, I'll keep my wallet closed.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer